NO922084L - Lipid-formuleringssystem - Google Patents

Lipid-formuleringssystem

Info

Publication number
NO922084L
NO922084L NO92922084A NO922084A NO922084L NO 922084 L NO922084 L NO 922084L NO 92922084 A NO92922084 A NO 92922084A NO 922084 A NO922084 A NO 922084A NO 922084 L NO922084 L NO 922084L
Authority
NO
Norway
Prior art keywords
lipid
matrix
particle forming
lipid particle
forming matrix
Prior art date
Application number
NO92922084A
Other languages
English (en)
Other versions
NO304729B1 (no
NO922084D0 (no
Inventor
Bengt Hersloef
Martin Nicklasson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of NO922084L publication Critical patent/NO922084L/no
Publication of NO922084D0 publication Critical patent/NO922084D0/no
Publication of NO304729B1 publication Critical patent/NO304729B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Colloid Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fertilizers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
NO921231A 1990-09-28 1992-05-26 Lipidpartikkeldannende matriks NO304729B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9003100A SE9003100D0 (sv) 1990-09-28 1990-09-28 Lipid formulation system
PCT/SE1991/000639 WO1992005771A1 (en) 1990-09-28 1991-09-24 Lipid formulation system

Publications (3)

Publication Number Publication Date
NO922084L true NO922084L (no) 1992-05-26
NO922084D0 NO922084D0 (no) 1992-05-26
NO304729B1 NO304729B1 (no) 1999-02-08

Family

ID=20380490

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921231A NO304729B1 (no) 1990-09-28 1992-05-26 Lipidpartikkeldannende matriks

Country Status (15)

Country Link
EP (1) EP0514506B1 (no)
JP (1) JP2855594B2 (no)
AT (1) ATE137667T1 (no)
AU (1) AU645143B2 (no)
CA (1) CA2069760C (no)
DE (1) DE69119400T2 (no)
DK (1) DK0514506T3 (no)
ES (1) ES2088024T3 (no)
FI (1) FI107696B (no)
GR (1) GR3020674T3 (no)
IE (1) IE62194B1 (no)
NO (1) NO304729B1 (no)
PT (1) PT99113B (no)
SE (1) SE9003100D0 (no)
WO (1) WO1992005771A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260065A (en) * 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
CA2182577C (en) * 1994-02-04 2002-08-20 Anders Carlsson Lipophilic carrier preparations
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
SE9703691D0 (sv) 1997-10-10 1997-10-10 Astra Ab Pharmaceutical compositions
GB2344520A (en) * 1998-12-08 2000-06-14 Phares Pharm Res Nv Pharmaceutical carriers comprising lipids and polymers
DE69825495T2 (de) 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
SE0200475D0 (sv) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral farmaceutisk beredning
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
FR2868704B1 (fr) * 2004-04-07 2007-09-14 Ethypharm Sa Utilisation de lipides pour ameliorer la biodisponibilite de principes actifs proteiques en formulations injectables sous cutanees ou intra-musculaires
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
EA012882B1 (ru) * 2005-04-28 2009-12-30 ДСМ АйПи ЭССЕТС Б.В. Фармацевтические лекарственные формы, содержащие липидную фазу
WO2007043057A2 (en) * 2005-10-11 2007-04-19 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
RU2319506C2 (ru) * 2005-10-12 2008-03-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Способ получения носителя антигенов на основе липидов из морских макрофитов и тритерпенового гликозида кукумариозида
RU2322259C1 (ru) * 2006-06-29 2008-04-20 Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" Носитель антигенов
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
CN101926757B (zh) * 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN117580560A (zh) * 2021-05-03 2024-02-20 Mcal治疗公司 微粉化脂质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
AU604288B2 (en) * 1987-01-26 1990-12-13 Vestar, Inc. Phospholipid delivery vehicle for aqueous-insoluble active ingredients

Also Published As

Publication number Publication date
AU645143B2 (en) 1994-01-06
IE62194B1 (en) 1994-12-28
FI922452A0 (fi) 1992-05-27
FI922452L (fi) 1992-05-27
NO304729B1 (no) 1999-02-08
NO922084D0 (no) 1992-05-26
JPH05503711A (ja) 1993-06-17
CA2069760C (en) 1998-02-10
FI107696B (fi) 2001-09-28
WO1992005771A1 (en) 1992-04-16
GR3020674T3 (en) 1996-10-31
AU8710591A (en) 1992-04-28
IE913246A1 (en) 1992-04-08
ES2088024T3 (es) 1996-08-01
ATE137667T1 (de) 1996-05-15
JP2855594B2 (ja) 1999-02-10
EP0514506B1 (en) 1996-05-08
SE9003100D0 (sv) 1990-09-28
DE69119400D1 (de) 1996-06-13
CA2069760A1 (en) 1992-03-29
EP0514506A1 (en) 1992-11-25
DK0514506T3 (da) 1996-08-12
PT99113A (pt) 1992-08-31
DE69119400T2 (de) 1996-12-05
PT99113B (pt) 1999-02-26

Similar Documents

Publication Publication Date Title
DK0514506T3 (da) Lipid-formuleringssystem
ES2081349T3 (es) Rotogranulaciones y recubrimientos para enmascarar el sabor para la preparacion de comprimidos farmaceuticos de mascar.
DK233080A (da) Overtraeksmiddel til foedevarer og medicinalvarer fremgangsmaade til fremstilling deraf samt produkter forsynet med et saadant overtraek
FR2778406B1 (fr) Derives d'alpha-cetoamides, procede pour leur preparation, preparations pharmaceutiques les contenant, et leur utilisation en tant que medicaments anti-viraux
DE68920394D1 (de) Heterozyklische Verbindungen und Arzneimittel, die die Wirkung von Antikrebsmitteln verstärken, welche diese als wirksame Bestandteile enthalten.
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
IE54084B1 (en) Medicaments with a high degree of solubility and method for their production
IL108071A0 (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
ES2078190B1 (es) Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
ES2080549T3 (es) Medicamentos a base de derivados de polihidroximetileno, procedimiento para su preparacion y empleo.
ES2131318T3 (es) Pelets.
KR900005990A (ko) 차전자(psyllium)-함유 생성물
ES2058988T3 (es) Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
Khan et al. Development of microencapsulation: A review of literature
IL82523A0 (en) Microbicidal compositions,their manufacture and drugs containing them
JPS5225015A (en) Process for preparing fine granular drugs
ATE28566T1 (de) Zellgiftiges arzneimittel enthaltend mindestens ein immunotoxin und ein amin.
FR2676648B1 (fr) Nouvelles compositions, leur procede de preparation et leurs applications comme substance active de medicament antigrippal ou antiviral.
BE862053A (fr) Peptides contenant de la phenylglycine utiles comme medicaments, procede pour leur preparation et compositions pharmaceutiques en contenant
BE874154A (fr) Derives de l'eburnamonine, leur preparation et medicaments contenant ces substances
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
KR100486794B1 (ko) 다른 상 운반체 사이에서 하나 또는 그 이상의 활성인자를 이동시키는 방법
Goodhart et al. Pharmaceutical sciences—1975: Literature review of pharmaceutics I
Food and Drug Administration, HHS Ingrown toenail relief drug products for over-the-counter human use. Final rule